SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-038713
Filing Date
2017-02-13
Accepted
2017-02-10 19:27:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d347373dsc13ga.htm SC 13G/A 36846
  Complete submission text file 0001193125-17-038713.txt   38675
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filed by) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Subject) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88987 | Film No.: 17595306
SIC: 2836 Biological Products, (No Diagnostic Substances)